Skip to content
healthcare.dev

RASAGILINE

NDC 42571-220, Rasagiline, tablet, from Micro Labs Limited.

Product NDC
42571-220
Status
Listed
Labeler
Micro Labs Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207004
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-220 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE.5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
42571-220-0542571022005500 TABLET in 1 BOTTLE (42571-220-05)
42571-220-10425710220101000 TABLET in 1 BOTTLE (42571-220-10)
42571-220-304257102203030 TABLET in 1 BOTTLE (42571-220-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/42f8d62f-2c57-47bc-92e7-b28111aa8cd1
  • NADAC price for package 42571022030

    GET /v1/drugs/nadac/42571022030

Use it

Look up 42571-220 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-220 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.